TY - JOUR
T1 - Percutaneous coronary intervention or coronary artery bypass graft surgery for left main coronary artery disease
T2 - A meta-analysis of randomized trials
AU - Kuno, Toshiki
AU - Ueyama, Hiroki
AU - Rao, Sunil V.
AU - Cohen, Mauricio G.
AU - Tamis-Holland, Jacqueline E.
AU - Thompson, Craig
AU - Takagi, Hisato
AU - Bangalore, Sripal
N1 - Publisher Copyright:
© 2020 Elsevier Inc.
Copyright:
Copyright 2020 Elsevier B.V., All rights reserved.
PY - 2020/9
Y1 - 2020/9
N2 - We aimed to investigate long-term (≥5 years) outcomes of percutaneous coronary intervention (PCI) versus coronary artery bypass grafting (CABG) for left main coronary artery disease (LMCAD) using a meta-analysis from updated published randomized trials. Our data showed that the risk of all-cause death as well as cardiovascular death, myocardial infarction, and stroke was similar between PCI and CABG, whereas PCI had significantly higher rates of repeat revascularization compared to CABG. Decisions for PCI versus CABG for LMCAD should be based on weighing the upfront morbidity and mortality risk of CABG with late risk of repeat revascularization with PCI and taking into consideration patient preference.
AB - We aimed to investigate long-term (≥5 years) outcomes of percutaneous coronary intervention (PCI) versus coronary artery bypass grafting (CABG) for left main coronary artery disease (LMCAD) using a meta-analysis from updated published randomized trials. Our data showed that the risk of all-cause death as well as cardiovascular death, myocardial infarction, and stroke was similar between PCI and CABG, whereas PCI had significantly higher rates of repeat revascularization compared to CABG. Decisions for PCI versus CABG for LMCAD should be based on weighing the upfront morbidity and mortality risk of CABG with late risk of repeat revascularization with PCI and taking into consideration patient preference.
UR - http://www.scopus.com/inward/record.url?scp=85087371092&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85087371092&partnerID=8YFLogxK
U2 - 10.1016/j.ahj.2020.06.001
DO - 10.1016/j.ahj.2020.06.001
M3 - Letter
C2 - 32640370
AN - SCOPUS:85087371092
VL - 227
SP - 9
EP - 10
JO - American Heart Journal
JF - American Heart Journal
SN - 0002-8703
ER -